News: Using opioids to treat addiction is considered the gold standard. So why aren’t more doctors prescribing them? (Philly.com)

“Doctors have basically been taught and raised and are functioning in a system where addiction is always someone else’s job,” said Priya Mammen, an emergency physician and public health advocate from South Philadelphia. “The regulations treat these medications as qualitatively different from any other medication we prescribe. It gives off Read more

By HepCAP, ago

Event: 5th Annual Jefferson Liver Disease Symposium

5th Annual Jefferson Liver Disease Symposium Saturday, March 30, 2019 Bluemle Life Sciences Building, Campus of Thomas Jefferson University233 S. 10th Street, Philadelphia, PA 19107 The 5th Annual Jefferson Liver Disease Symposium will feature a multi-disciplinary approach to the treatment and management of patients with a potpourri of liver diseases presenting in the office of Read more

By HepCAP, ago

Training: Treating Hepatitis C in Primary Care

Community Liver Alliance is offering a CME training on Treating Hepatitis C in Primary Care settings! Who Should Attend? This program is directed to primary care physicians, specialists (Infectious Disease, Gastroenterology, Hepatology), advanced practice provides, nurses, public health professionals, drug and alcohol counselors, care coordinators, advocates and other allied health Read more

By HepCAP, ago

News: Washington takes ‘Netflix’ hep C drug pricing further with winner-take-all bidding (FiercePharma)

Officials in Washington are seeking proposals from pharma companies for a “winner take all” hep C procurement deal It’s not just Louisiana working to tackle hepatitis C by purchasing drugs in a novel way. Officials in Washington are taking that state’s Netflix-style subscription model and upping the ante with a winner-take-all contract. Read more

By HepCAP, ago